The doctors at Slade & Baker Vision are very pleased to announce the FDA approval of Corneal Cross-Linking (CXL) for Keratoconus and Corneal Ectasia.rnrnThe doctors at Slade & Baker Vision have been involved in CXL for years, including the FDA studies with Avedro. Please read this blog for more information!
For those of you who have not heard of keratoconus, it is a corneal disease that causes structural changes within the cornea causing the cornea to thin and bulge outward into a steeper, irregular, more conical shape than its normal gradual curve. Keratoconus can cause substantial visual loss of vision, image distortion, streaking of lights, sensitivity to light, and multiple images, etc. Keratoconus affects about one person in a thousand, and yet the exact cause of it is uncertain.
Dr. Slade has been involved with finding a safe treatment for keratoconus from its discovery and this has been an ongoing effort for several years. He has been interviewed and featured in this article of Ocular Surgery News. Click on this blog to read more!
An exciting new update in corneal collagen crosslinking (CXL) arrives in Houston, Texas!
Read more about Slade & Baker Vision Center’s ongoing dedication to finding a stop to keratoconus and post lasik ectasia!
Please click on this link for the ACOS press release about this new and exciting corneal crosslinking trial for Keratoconus.